SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/19 – ‘R12’

On:  Friday, 2/14/20, at 5:18pm ET   ·   For:  12/31/19   ·   Accession #:  731766-20-6   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/12/19 for 12/31/18   ·   Next:  ‘10-K’ on 3/1/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/14/20  Unitedhealth Group Inc            10-K       12/31/19  112:20M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.43M 
 2: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     34K 
 3: EX-10.17    Material Contract                                   HTML    217K 
 4: EX-10.18    Material Contract                                   HTML     38K 
 5: EX-10.44    Material Contract                                   HTML     73K 
 6: EX-10.45    Material Contract                                   HTML     36K 
 7: EX-10.46    Material Contract                                   HTML     37K 
 8: EX-21.1     Subsidiaries List                                   HTML    298K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
10: EX-24.1     Power of Attorney                                   HTML     39K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     46K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
22: R1          Cover Document                                      HTML     96K 
79: R2          Consolidated Balance Sheets                         HTML    133K 
89: R3          Consolidated Balance Sheet (Parenthetical)          HTML     58K 
59: R4          Consolidated Statements of Operations               HTML    107K 
23: R5          Consolidated Statements of Comprehensive Income     HTML     76K 
80: R6          Consolidated Statements of Changes in Equity        HTML    109K 
90: R7          Consolidated Statement of Changes in Equity         HTML     33K 
                (Parentheticals)                                                 
58: R8          Consolidated Statements of Cash Flows               HTML    132K 
24: R9          Description of Business (Notes)                     HTML     32K 
108: R10         Basis of Presentation, Uses of Estimates and        HTML     96K  
                Significant Accounting Policies (Notes)                          
75: R11         Investments (Notes)                                 HTML    213K 
40: R12         Fair Value (Notes)                                  HTML    151K 
53: R13         Property, Plant, and Capitalized Software (Notes)   HTML     54K 
109: R14         Goodwill and Intangible Assets (Notes)              HTML    115K  
76: R15         Medical Costs Payable (Notes)                       HTML     81K 
41: R16         Commercial Paper and Long-Term Debt (Notes)         HTML    260K 
54: R17         Income Taxes (Notes)                                HTML    163K 
110: R18         Shareholders' Equity (Notes)                        HTML     51K  
74: R19         Share-Based Compensation (Notes)                    HTML    110K 
19: R20         Commitments and Contingencies (Notes)               HTML     54K 
55: R21         Business Combinations Business Combinations         HTML     44K 
                (Notes)                                                          
92: R22         Segment Financial Information (Notes)               HTML    308K 
81: R23         Quarterly Financial Data (Unaudited) (Notes)        HTML     82K 
20: R24         Schedule I (Notes)                                  HTML    202K 
56: R25         Basis of Presentation, Uses of Estimates and        HTML    153K 
                Significant Accounting Policies (Policies)                       
93: R26         Fair Value Fair Value (Policies)                    HTML     44K 
82: R27         Schedule I (Policies)                               HTML    122K 
18: R28         Basis of Presentation, Uses of Estimates and        HTML     71K 
                Significant Accounting Policies (Tables)                         
57: R29         Investments (Tables)                                HTML    209K 
52: R30         Fair Value (Tables)                                 HTML    143K 
38: R31         Property, Plant, and Capitalized Software (Tables)  HTML     52K 
78: R32         Goodwill and Intangible Assets (Tables)             HTML    122K 
112: R33         Medical Costs Payable (Tables)                      HTML     83K  
51: R34         Commercial Paper and Long-Term Debt (Tables)        HTML    262K 
37: R35         Income Taxes (Tables)                               HTML    165K 
77: R36         Shareholders' Equity (Tables)                       HTML     49K 
111: R37         Share-Based Compensation (Tables)                   HTML    115K  
49: R38         Commitments and Contingencies (Tables)              HTML     45K 
39: R39         Business Combinations Business Combinations         HTML     41K 
                (Tables)                                                         
65: R40         Segment Financial Information (Tables)              HTML    300K 
28: R41         Quarterly Financial Data (Unaudited) (Tables)       HTML     82K 
85: R42         Schedule I (Tables)                                 HTML    208K 
95: R43         Basis of Presentation, Uses of Estimates and        HTML     96K 
                Significant Accounting Policies (Details)                        
63: R44         Basis of Presentation, Uses of Estimates and        HTML     43K 
                Significant Accounting Policies Useful lives for                 
                property, equipment and capitalized software                     
                (Details)                                                        
27: R45         Basis of Presentation, Uses of Estimates and        HTML     56K 
                Significant Accounting Policies Redeemable                       
                Noncontrolling Interests (Details)                               
84: R46         Investments (Narrative) (Details)                   HTML     42K 
94: R47         Investments (Short-Term and Long-Term Investments)  HTML     82K 
                (Details)                                                        
62: R48         Investments (Amortized Cost and Fair Value of       HTML    104K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
29: R49         Investments (Fair Value of Available-For-Sale       HTML     67K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
35: R50         Fair Value (Narrative) (Details)                    HTML     39K 
46: R51         Fair Value (Financial Assets and Liabilities,       HTML     88K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
100: R52         Fair Value (Financial Assets and Liabilities, Not   HTML     56K  
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
66: R53         Property, Plant, and Capitalized Software           HTML     36K 
                (Narrative) (Details)                                            
36: R54         Property, Plant, and Capitalized Software Property  HTML     56K 
                Plant and Equipment Table (Details)                              
47: R55         Goodwill and Intangible Assets (Narrative)          HTML     34K 
                (Details)                                                        
101: R56         Goodwill and Intangible Assets Changes in the       HTML     51K  
                Carrying Amount of Goodwill by Reporting Segment                 
                (Details)                                                        
67: R57         Goodwill and Intangible Assets Gross carrying       HTML     49K 
                value, accumulated amortization and net carrying                 
                value of intangible assets (Details)                             
34: R58         Goodwill and Intangible Assets Weighted-average     HTML     43K 
                useful lives assigned to finite-lived intangible                 
                assets acquired in business combinations (Details)               
48: R59         Goodwill and Intangible Assets Amortization         HTML     43K 
                Expense relating to Intangible Assets (Details)                  
96: R60         Medical Costs Payable (Narrative) (Details)         HTML     31K 
87: R61         Medical Costs Payable Rollforward (Details)         HTML     55K 
25: R62         Medical Costs Payable, Incurred and Paid Medical    HTML     46K 
                Cost Development (Details)                                       
60: R63         Commercial Paper and Long-Term Debt (Narrative)     HTML     61K 
                (Details)                                                        
98: R64         Commercial Paper and Long-Term Debt (Details)       HTML    210K 
88: R65         Commercial Paper and Long-Term Debt Maturities of   HTML     48K 
                commercial paper and long-term debt (Details)                    
26: R66         Income Taxes (Narrative) (Details)                  HTML     65K 
61: R67         Income Taxes Reconciliation of Provision for        HTML     49K 
                Income Taxes (Details)                                           
99: R68         Income Tax Reconciliation of the tax provision at   HTML     86K 
                the U.S. Federal Statutory Rate (Details)                        
86: R69         Income Taxes Components of Deferred Tax Assets and  HTML     90K 
                Liabilities (Details)                                            
71: R70         Income Taxes Reconciliation of the beginning and    HTML     46K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
107: R71         Shareholders' Equity (Narrative) (Details)          HTML     43K  
45: R72         Shareholders' Equity Share Repurchases (Details)    HTML     42K 
33: R73         Share-Based Compensation (Narrative) (Details)      HTML     38K 
68: R74         Share-Based Compensation (Stock Option Activity)    HTML     80K 
                (Details)                                                        
104: R75         Share-Based Compensation (Restricted Share          HTML     48K  
                Activity) (Details)                                              
42: R76         Share-Based Compensation Other Share-Based          HTML     63K 
                Compensation Data (Details)                                      
30: R77         Share-Based Compensation (Share-Based Compensation  HTML     58K 
                Principal Fair Value Assumptions) (Details)                      
73: R78         Commitments and Contingencies (Narrative)           HTML     47K 
                (Details)                                                        
103: R79         Commitments and Contingencies Future Lease          HTML     55K  
                Payments (Details)                                               
70: R80         Business Combinations Acquired Assets and           HTML     49K 
                Liabilities (Details)                                            
106: R81         Business Combinations Business Combinations         HTML     39K  
                (Details)                                                        
44: R82         Segment Financial Information (Narrative)           HTML     45K 
                (Details)                                                        
32: R83         Segment Financial Information (Details)             HTML    125K 
69: R84         Quarterly Financial Data (Unaudited) (Details)      HTML     70K 
105: R85         Schedule I (Details)                                HTML     43K  
43: R86         Schedule I Condensed Balance Sheets (Details)       HTML    113K 
31: R87         Schedule I Balance Sheet Document (Details)         HTML     52K 
72: R88         Schedule I Condensed Statement of Comprehensive     HTML     73K 
                Income (Details)                                                 
102: R89         Schedule I Statement of Cash Flows (Details)        HTML    109K  
97: R90         Schedule I Maturities of Commercial Paper and       HTML     52K 
                Long-Term Debt (Details)                                         
50: XML         IDEA XML File -- Filing Summary                      XML    203K 
64: XML         XBRL Instance -- unh2019123110-k_htm                 XML   5.37M 
83: EXCEL       IDEA Workbook of Financial Reports                  XLSX    133K 
14: EX-101.CAL  XBRL Calculations -- unh-20191231_cal                XML    310K 
15: EX-101.DEF  XBRL Definitions -- unh-20191231_def                 XML   1.42M 
16: EX-101.LAB  XBRL Labels -- unh-20191231_lab                      XML   2.46M 
17: EX-101.PRE  XBRL Presentations -- unh-20191231_pre               XML   1.68M 
13: EX-101.SCH  XBRL Schema -- unh-20191231                          XSD    232K 
91: JSON        XBRL Instance as JSON Data -- MetaLinks              515±   798K 
21: ZIP         XBRL Zipped Folder -- 0000731766-20-000006-xbrl      Zip    654K 


‘R12’   —   Fair Value (Notes)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.19.3.a.u2
Fair Value (Notes)
12 Months Ended
Fair Value Disclosures [Abstract]  
Fair Value [Text Block]
Fair Value
Certain assets and liabilities are measured at fair value in the Consolidated Financial Statements or have fair values disclosed in the Notes to the Consolidated Financial Statements. These assets and liabilities are classified into one of three levels of a hierarchy defined by GAAP. In instances in which the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement is categorized in its entirety based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.
The fair value hierarchy is summarized as follows:
Level 1 — Quoted prices (unadjusted) for identical assets/liabilities in active markets.
Level 2 — Other observable inputs, either directly or indirectly, including:
Quoted prices for similar assets/liabilities in active markets;
Quoted prices for identical or similar assets/liabilities in inactive markets (e.g., few transactions, limited information, noncurrent prices, high variability over time);
Inputs other than quoted prices that are observable for the asset/liability (e.g., interest rates, yield curves, implied volatilities, credit spreads); and
Inputs that are corroborated by other observable market data.
Level 3 — Unobservable inputs that cannot be corroborated by observable market data.
There were no transfers in or out of Level 3 financial assets or liabilities during the years ended December 31, 2019 or 2018.
Nonfinancial assets and liabilities or financial assets and liabilities that are measured at fair value on a nonrecurring basis are subject to fair value adjustments only in certain circumstances, such as when the Company records an impairment. There were no significant fair value adjustments for these assets and liabilities recorded during the years ended December 31, 2019 or 2018.
The following methods and assumptions were used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument included in the tables below:
Cash and Cash Equivalents. The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.
Debt and Equity Securities. Fair values of debt and equity securities are based on quoted market prices, where available. The Company obtains one price for each security primarily from a third-party pricing service (pricing service), which generally uses quoted or other observable inputs for the determination of fair value. The pricing service normally derives the security prices through recently reported trades for identical or similar securities, and, if necessary, makes adjustments through the reporting date based upon available observable market information. For securities not actively traded, the pricing service may use quoted market prices of comparable instruments or discounted cash flow analyses, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include, but are not limited to, benchmark yields, credit spreads, default rates, prepayment speeds and nonbinding broker quotes. As the Company is responsible for the determination of fair value, it performs quarterly analyses on the prices received from the pricing service to determine whether the prices are reasonable estimates of fair value. Specifically, the Company compares the prices received from the pricing service to prices reported by a secondary pricing source, such as its custodian, its investment consultant and third-party investment advisors. Additionally, the Company compares changes in the reported market values and returns to relevant market indices to test the reasonableness of the reported prices. The Company’s internal price verification procedures and reviews of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment to the prices obtained from the pricing service.
Fair values of debt securities that do not trade on a regular basis in active markets but are priced using other observable inputs are classified as Level 2.
Fair value estimates for Level 1 and Level 2 equity securities are based on quoted market prices for actively traded equity securities and/or other market data for the same or comparable instruments and transactions in establishing the prices.
The fair values of Level 3 investments in corporate bonds, which are not a significant portion of our investments, are estimated using valuation techniques that rely heavily on management assumptions and qualitative observations.
Throughout the procedures discussed above in relation to the Company’s processes for validating third-party pricing information, the Company validates the understanding of assumptions and inputs used in security pricing and determines the proper classification in the hierarchy based on that understanding.
Assets Under Management. Assets under management consists of debt securities and other investments held to fund costs associated with the AARP Program and are priced and classified using the same methodologies as the Company’s investments in debt and equity securities.
Long-Term Debt. The fair values of the Company’s long-term debt are estimated and classified using the same methodologies as the Company’s investments in debt securities.
The following table presents a summary of fair value measurements by level and carrying values for items measured at fair value on a recurring basis in the Consolidated Balance Sheets:
(in millions)
 
Quoted Prices
in Active
Markets
(Level 1)
 
Other
Observable
Inputs
(Level 2)
 
Unobservable
Inputs
(Level 3)
 
Total
Fair and Carrying
Value
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
10,837

 
$
148

 
$

 
$
10,985

Debt securities - available-for-sale:
 
 
 
 
 
 
 
 
U.S. government and agency obligations
 
3,369

 
184

 

 
3,553

State and municipal obligations
 

 
5,926

 

 
5,926

Corporate obligations
 
70

 
17,923

 
249

 
18,242

U.S. agency mortgage-backed securities
 

 
6,528

 

 
6,528

Non-U.S. agency mortgage-backed securities
 

 
1,845

 

 
1,845

Total debt securities - available-for-sale
 
3,439

 
32,406

 
249

 
36,094

Equity securities
 
1,734

 
22

 

 
1,756

Assets under management
 
1,123

 
1,918

 
35

 
3,076

Total assets at fair value

$
17,133

 
$
34,494

 
$
284

 
$
51,911

Percentage of total assets at fair value
 
33
%
 
66
%
 
1
%
 
100
%
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
10,757

 
$
109

 
$

 
$
10,866

Debt securities - available-for-sale:
 
 
 
 
 
 
 
 
U.S. government and agency obligations
 
3,060

 
345

 

 
3,405

State and municipal obligations
 

 
7,121

 

 
7,121

Corporate obligations
 
39

 
14,950

 
173

 
15,162

U.S. agency mortgage-backed securities
 

 
4,852

 

 
4,852

Non-U.S. agency mortgage-backed securities
 

 
1,358

 

 
1,358

Total debt securities - available-for-sale
 
3,099

 
28,626

 
173

 
31,898

Equity securities
 
1,832

 
13

 

 
1,845

Assets under management
 
1,086

 
1,938

 
8

 
3,032

Total assets at fair value
 
$
16,774

 
$
30,686

 
$
181

 
$
47,641

Percentage of total assets at fair value
 
35
%
 
65
%
 
%
 
100
%

The following table presents a summary of fair value measurements by level and carrying values for certain financial instruments not measured at fair value on a recurring basis in the Consolidated Balance Sheets:
(in millions)
 
Quoted Prices
in Active
Markets
(Level 1)
 
Other
Observable
Inputs
(Level 2)
 
Unobservable
Inputs
(Level 3)
 
Total
Fair
Value
 
Total Carrying Value
 
 
 
 
 
 
 
 
 
 
Debt securities - held-to-maturity
 
$
541

 
$
181

 
$
253

 
$
975

 
$
972

Long-term debt and other financing obligations
 
$

 
$
45,078

 
$

 
$
45,078

 
$
40,278

 
 
 
 
 
 
 
 
 
 
Debt securities - held-to-maturity
 
$
260

 
$
65

 
$
295

 
$
620

 
$
621

Long-term debt and other financing obligations
 
$

 
$
37,944

 
$

 
$
37,944

 
$
36,554


The carrying amounts reported on the Consolidated Balance Sheets for other current financial assets and liabilities approximate fair value because of their short-term nature. These assets and liabilities are not listed in the table above.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/14/20SC 13G
For Period end:12/31/1911-K
12/31/1810-K,  11-K,  4
 List all Filings 


16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  UnitedHealth Group Inc.           10-K       12/31/23  119:19M
 3/03/23  UnitedHealth Group Inc.           S-8         3/03/23    9:419K
 2/24/23  UnitedHealth Group Inc.           10-K       12/31/22  119:19M
 2/22/23  UnitedHealth Group Inc.           S-8         2/22/23    7:276K                                   Toppan Merrill/FA
10/26/22  UnitedHealth Group Inc.           424B5                  2:490K                                   Donnelley … Solutions/FA
10/25/22  UnitedHealth Group Inc.           424B5                  1:421K                                   Donnelley … Solutions/FA
10/03/22  UnitedHealth Group Inc.           S-8        10/03/22    7:438K                                   Toppan Merrill/FA
 8/18/22  UnitedHealth Group Inc.           S-8         8/18/22    5:89K                                    Donnelley … Solutions/FA
 5/18/22  UnitedHealth Group Inc.           424B5                  2:477K                                   Donnelley … Solutions/FA
 5/17/22  UnitedHealth Group Inc.           424B5                  1:403K                                   Donnelley … Solutions/FA
 2/15/22  UnitedHealth Group Inc.           10-K       12/31/21  113:19M
10/29/21  UnitedHealth Group Inc.           S-8        10/29/21    5:264K
10/29/21  UnitedHealth Group Inc.           S-8        10/29/21    4:175K
 5/18/21  UnitedHealth Group Inc.           424B5                  1:435K                                   Donnelley … Solutions/FA
 5/17/21  UnitedHealth Group Inc.           424B5                  1:407K                                   Donnelley … Solutions/FA
 3/01/21  UnitedHealth Group Inc.           10-K       12/31/20  107:17M
Top
Filing Submission 0000731766-20-000006   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 11:14:24.1am ET